SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-23-005013
Filing Date
2023-10-05
Accepted
2023-10-05 16:15:15
Documents
1
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5303
  Complete submission text file 0000902664-23-005013.txt   7277
Mailing Address 640 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address
ALTMAN JEFFREY A (Reporting) CIK: 0001269751 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40608 | Film No.: 231311512

Mailing Address 640 FIFTH AVENUE 20TH FLOOR NEW YORK NY 10019
Business Address 640 FIFTH AVENUE 20TH FLOOR NEW YORK NY 10019 212-688-2550
Owl Creek Asset Management, L.P. (Reporting) CIK: 0001313756 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40608 | Film No.: 231311513

Mailing Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Issuer) CIK: 0001844417 (see all company filings)

IRS No.: 861314502 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)